Paradigm Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$83.4K Hold
455
0.02% 341
2025
Q4
$80.1K Hold
455
0.02% 358
2025
Q3
$63.7K Hold
455
0.01% 367
2025
Q2
$57.1K Hold
455
0.01% 385
2025
Q1
$62.3K Hold
455
0.02% 380
2024
Q4
$69.6K Hold
455
0.02% 361
2024
Q3
$88.2K Hold
455
0.02% 337
2024
Q2
$105K Hold
455
0.03% 316
2024
Q1
$98.1K Hold
455
0.02% 348
2023
Q4
$118K Hold
455
0.03% 338
2023
Q3
$117K Hold
455
0.03% 336
2023
Q2
$130K Hold
455
0.03% 327
2023
Q1
$127K Sell
455
-50
-10% -$13.8K 0.03% 322
2022
Q4
$140K Sell
505
-6,300
-93% -$1.78M 0.04% 324
2022
Q3
$1.82M Sell
6,805
-100
-1% -$21.2K 0.61% 40
2022
Q2
$1.41M Sell
6,905
-700
-9% -$143K 0.43% 51
2022
Q1
$1.6M Hold
7,605
0.42% 61
2021
Q4
$1.82M Buy
7,605
+405
+6% +$104K 0.46% 57
2021
Q3
$2.04M Sell
7,200
-400
-5% -$131K 0.56% 44
2021
Q2
$2.63M Hold
7,600
0.67% 30
2021
Q1
$2.13M Sell
7,600
-300
-4% -$80.9K 0.57% 37
2020
Q4
$1.93M Buy
+7,900
New +$2.04M 0.54% 44
2014
Q2
Sell
-2,550
Closed -$780K 788
2014
Q1
$780K Hold
2,550
0.11% 210
2013
Q4
$713K Buy
+2,550
New +$660K 0.11% 225

Other funds holding BIIB

Paradigm Asset Management's BIIB Position: Q1 2026 in Review

Paradigm Asset Management held its Biogen (BIIB) position steady in Q1 2026 at 455 shares worth $83.4K. The position accounts for 0.02% of the portfolio, ranked #341.

Paradigm Asset Management first reported a position in BIIB in Q4 2013 and has held it in 24 quarters since. The position peaked at $2.63M in Q2 2021. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Paradigm Asset Management held 455 shares of Biogen worth $83.4K as of Q1 2026.
  • Paradigm Asset Management left its Biogen share count unchanged in Q1 2026.
  • Biogen made up 0.02% of Paradigm Asset Management's portfolio in Q1 2026, its #341 holding.
  • Paradigm Asset Management first reported a position in Biogen in Q4 2013 and has held it in 24 quarters since.
  • Paradigm Asset Management's Biogen position peaked at $2.63M in Q2 2021.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Paradigm Asset Management's 13F filing for Q1 2026, filed 12 May 2026.